The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Vulnerable patients with metastatic colorectal cancer in a real-world setting: A multicenter retrospective study.
 
Seiichiro Mitani
Honoraria - Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Chugai Pharma
Research Funding - Lilly; Taiho Pharmaceutical
 
Yosuke Kito
Honoraria - Daiichi Sakyo; Merck; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
 
Kaori Hino
No Relationships to Disclose
 
Kentaro Kawakami
No Relationships to Disclose
 
Naoki Izawa
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kissei Pharmaceutical; Lilly; Taiho Pharmaceutical; Takeda
Research Funding - Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst)
 
Fumiyasu Hanamura
No Relationships to Disclose
 
Yoshiyuki Yamamoto
Honoraria - Bayer; Bristol-Myers Squibb Japan; Daiichi Sankyo; Insight; Lilly; Merck Serono; Ono Pharmaceutical; SERVIER; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
 
Hirokazu Shoji
No Relationships to Disclose
 
Azusa Komori
No Relationships to Disclose
 
Shogen Boku
Speakers' Bureau - Chugai Pharma; Daiichi Sankyo Co. Ltd.; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Daiichi Sankyo Co. Ltd. (Inst)
 
Kenji Tsuchihashi
No Relationships to Disclose
 
Eishi Baba
Honoraria - Chugai Pharma; Daiichi Sankyo; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Daiichi Sankyo
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly; Merck; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Kyoko Kato
No Relationships to Disclose
 
Yoshikane Nonagase
No Relationships to Disclose
 
Toshihiko Matsumoto
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical
 
Mitsuhiro Furuta
Honoraria - Bristol-Myers Squibb Company; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
 
Hisato Kawakami
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai/Roche; Daiichi Sankyo; Lilly Japan; Merck Serono; MSD K.K; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb Japan; Daiichi Sankyo Co. Ltd.,; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kobayashi Pharmaceutical (Inst)